Serina Therapeutics, Inc.SERNYSE
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank0
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P0
Near historical low
vs 3Y Ago
-8.3x
Contraction
Streak
3 yr
Consecutive declineDecelerating
PeriodValue
2024-592.12%
2023-19.29%
20227.78%
202171.21%
202023.06%
2019-27.08%
2018-27.21%
201725.42%
20160.00%